Pfizer Expands Product Offering In Accord Initiative To Around 500 Products

Pfizer Inc. (PFE) announced Tuesday the expansion of 'An Accord for a Healthier World' product offering to include the full portfolio of medicines and vaccines for which it has global rights on a not-for-profit basis to lower-income countries.

The Accord, launched in May 2022, is an initiative focused to reduce health inequities between many lower-income countries and the rest of the world.

The expanded product offering will include off-patent products, bringing the total offering to around 500 products from 23 products. It will give health benefits to 1.2 billion people living in 45 lower-income countries.

Pfizer's initial commitment to the Accord included access to all its patented medicines and vaccines available in the U.S. or European Union on a not-for-profit basis to 45 lower-income countries.

The Accord portfolio offering now includes both patented and off-patent medicines and vaccines that treat or prevent many infectious and non-communicable disease threats faced in lower-income countries.

As Pfizer launches new medicines and vaccines, those products will also be included in the Accord portfolio on a not-for-profit basis.

For More Such Health News, visit rttnews.com

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT